148 related articles for article (PubMed ID: 2646419)
21. The evaluation of cystatin C, IL-1beta, and TNF-alpha levels in total saliva and gingival crevicular fluid from 11- to 16-year-old children.
Ulker AE; Tulunoglu O; Ozmeric N; Can M; Demirtas S
J Periodontol; 2008 May; 79(5):854-60. PubMed ID: 18454664
[TBL] [Abstract][Full Text] [Related]
22. Gingival crevicular fluid matrix metalloproteinase (MMP)-7, extracellular MMP inducer, and tissue inhibitor of MMP-1 levels in periodontal disease.
Emingil G; Tervahartiala T; Mãntylã P; Määttä M; Sorsa T; Atilla G
J Periodontol; 2006 Dec; 77(12):2040-50. PubMed ID: 17209789
[TBL] [Abstract][Full Text] [Related]
23. Levels of pentraxin-3 in gingival crevicular fluid and plasma in periodontal health and disease.
Pradeep AR; Kathariya R; Raghavendra NM; Sharma A
J Periodontol; 2011 May; 82(5):734-41. PubMed ID: 21080790
[TBL] [Abstract][Full Text] [Related]
24. Crevicular fluid interleukin-1beta, tumor necrosis factor-alpha, and interleukin-6 levels in renal transplant patients receiving cyclosporine A.
Atilla G; Kütükçüler N
J Periodontol; 1998 Jul; 69(7):784-90. PubMed ID: 9706856
[TBL] [Abstract][Full Text] [Related]
25. Gingival crevicular fluid matrix metalloproteinase-25 and -26 levels in periodontal disease.
Emingil G; Kuula H; Sorsa T; Atilla G
J Periodontol; 2006 Apr; 77(4):664-71. PubMed ID: 16584348
[TBL] [Abstract][Full Text] [Related]
26. Soluble CD14 levels in gingival crevicular fluid of subjects with untreated adult periodontitis.
Jin L; Darveau RP
J Periodontol; 2001 May; 72(5):634-40. PubMed ID: 11394399
[TBL] [Abstract][Full Text] [Related]
27. Gingival crevicular fluid levels of osteoprotegerin (OPG) in premenopausal and postmenopausal women with or without chronic periodontitis.
Babür C; Ozcan G; Cebi DU; Pervane B; Ozdemir B; Yücel A; Biri AA; Babür C
J Dent; 2012 May; 40(5):364-71. PubMed ID: 22326720
[TBL] [Abstract][Full Text] [Related]
28. Raised chondroitin sulphate WF6 epitope levels in gingival crevicular fluid in chronic periodontitis.
Khongkhunthian S; Srimueang N; Krisanaprakornkit S; Pattanaporn K; Ong-Chai S; Kongtawelert P
J Clin Periodontol; 2008 Oct; 35(10):871-6. PubMed ID: 18727658
[TBL] [Abstract][Full Text] [Related]
29. Gingival crevicular fluid levels of oncostatin M in periodontal conditions.
Thorat Manojkumar S; Pradeep AR; Garg G; Raju A
Cytokine; 2010 Jun; 50(3):248-52. PubMed ID: 20189410
[TBL] [Abstract][Full Text] [Related]
30. Gingival crevicular fluid transforming growth factor-beta1 in several forms of periodontal disease.
Gürkan A; Emingil G; Cinarcik S; Berdeli A
Arch Oral Biol; 2006 Oct; 51(10):906-12. PubMed ID: 16787634
[TBL] [Abstract][Full Text] [Related]
31. [Relationship of serum and gingival crevicular fluid antibody levels with the amount of subgingival homologous bacterium in patients with periodontal disease].
OuYang XY
Zhonghua Kou Qiang Yi Xue Za Zhi; 1994 Mar; 29(2):72-4, 127. PubMed ID: 8001430
[TBL] [Abstract][Full Text] [Related]
32. Effect of periodontal therapy on crevicular fluid interleukin-1beta and interleukin-10 levels in chronic periodontitis.
Goutoudi P; Diza E; Arvanitidou M
J Dent; 2004 Sep; 32(7):511-20. PubMed ID: 15304296
[TBL] [Abstract][Full Text] [Related]
33. Gingival crevicular fluid osteopontin levels in periodontal health and disease.
Sharma CG; Pradeep AR
J Periodontol; 2006 Oct; 77(10):1674-80. PubMed ID: 17032109
[TBL] [Abstract][Full Text] [Related]
34. Fluid dynamics of gingiva in diabetic and systemically healthy periodontitis patients.
Sakallioğlu EE; Lütfioğlu M; Sakallioğlu U; Diraman E; Keskiner I
Arch Oral Biol; 2008 Jul; 53(7):646-51. PubMed ID: 18281015
[TBL] [Abstract][Full Text] [Related]
35. Adjunctive subantimicrobial dose doxycycline: effect on clinical parameters and gingival crevicular fluid transforming growth factor-beta levels in severe, generalized chronic periodontitis.
Gürkan A; Cinarcik S; Hüseyinov A
J Clin Periodontol; 2005 Mar; 32(3):244-53. PubMed ID: 15766366
[TBL] [Abstract][Full Text] [Related]
36. Analysis of human gingival tissue and gingival crevicular fluid beta-glucuronidase activity in specific periodontal diseases.
Layik M; Yamalik N; Caglayan F; Kilinç K; Etikan I; Eratalay K
J Periodontol; 2000 Apr; 71(4):618-24. PubMed ID: 10807127
[TBL] [Abstract][Full Text] [Related]
37. Levels of cytokine receptor activator of nuclear factor kappaB ligand in gingival crevicular fluid in untreated chronic periodontitis patients.
Vernal R; Chaparro A; Graumann R; Puente J; Valenzuela MA; Gamonal J
J Periodontol; 2004 Dec; 75(12):1586-91. PubMed ID: 15732858
[TBL] [Abstract][Full Text] [Related]
38. Acute-phase proteins and immunoglobulin G against Porphyromonas gingivalis in peri-implant crevicular fluid: a comparison with gingival crevicular fluid.
Adonogianaki E; Mooney J; Wennström JL; Lekholm U; Kinane DF
Clin Oral Implants Res; 1995 Mar; 6(1):14-23. PubMed ID: 7545442
[TBL] [Abstract][Full Text] [Related]
39. Plasminogen activator system in smokers and non-smokers with and without periodontal disease.
Buduneli N; Buduneli E; Kardeşler L; Lappin D; Kinane DF
J Clin Periodontol; 2005 Apr; 32(4):417-24. PubMed ID: 15811061
[TBL] [Abstract][Full Text] [Related]
40. Levels of specific immunoglobulin G to Porphyromonas gingivalis in gingival crevicular fluid are related to site disease status.
Mooney J; Kinane DF
Oral Microbiol Immunol; 1997 Apr; 12(2):112-6. PubMed ID: 9227135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
